Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma.

A case report of a 26-year-old man who is presented with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma, is presented. Topics include cladribine is discussed along with clinical, morphological, immunophenotypic, molecular, genetic, and cytogenetic features; and cytoplasm was basophilic, without granulation while a proportion of the cells showed small membranous protrusions.